Earth Science Tech Inc. (OTC: ETST) reported a transformational fiscal year ended March 31, 2026, marked by strategic share repurchases, expansion of its healthcare platform, and continued cash-flow generation, according to the company's annual shareholder letter. The holding company, which focuses on healthcare, pharmaceutical compounding, telemedicine, real estate, and other operating businesses, highlighted several key operational milestones that underscore its growth strategy and commitment to shareholder value.
Since fiscal Q1 2026, Earth Science Tech has repurchased and retired more than 6.9 million shares of common stock, reflecting management's focus on reducing share dilution. This repurchase program is a defining element of ETST's capital allocation approach, as detailed in the shareholder letter available at https://ibn.fm/WX3CI. The company also reported that its key operating businesses, including DOConsultation, Villas Health, and MOC Teledoc, are now cash-flow positive, signaling a shift toward self-sustaining operations.
In the health and wellness segment, Peaks Curative surpassed $2 million in revenue during the first week of fiscal Q4 2026, reflecting strong growth. Management emphasized that all expansion initiatives were completed without adding debt to the balance sheet, maintaining a disciplined capital structure. CEO and Chairman Giorgio R. Saumat described fiscal 2026 as a year in which the company strengthened its foundation for future growth while remaining debt-free.
Investors will have an opportunity to hear directly from management when Saumat presents at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17. The company's transformation from a wellness-focused enterprise into a diversified healthcare holding company has been a central theme, and the latest results demonstrate progress in executing that strategy.
The implications of these developments are significant for shareholders and the industry. The share repurchase program directly enhances shareholder value by reducing the number of outstanding shares, while the cash-flow-positive status of key subsidiaries indicates operational efficiency and reduced reliance on external funding. Achieving revenue milestones in the health and wellness segment, such as Peaks Curative's performance, suggests growing demand for the company's offerings.
By expanding without incurring debt, Earth Science Tech maintains financial flexibility and minimizes risk, which is particularly important in the capital-intensive healthcare sector. This disciplined approach could position the company for sustainable long-term growth and make it more resilient to economic fluctuations. For the industry, ETST's model of integrating telemedicine, pharmaceutical compounding, and real estate under a debt-free holding company structure may serve as a case study in strategic diversification.
As Earth Science Tech continues to execute its growth strategy, the focus on cash-flow generation and shareholder returns will likely remain key priorities. The upcoming investor conference provides an opportunity for stakeholders to gain further insights into the company's plans and vision for the future.
